Acute Subjective Effects, Physiological Effects, and Pharmacokinetics of Intravenous 5-MeO-DMT Infusions in a Double-blind, Placebo-controlled, Single Ascending Dose Study in Healthy Participants

Phase: PHASE1 | Sponsor: University Hospital, Basel, Switzerland | Compound: DMT

Status

recruiting

Institution

University Hospital, Basel, Switzerland

Start date

2026-03-31

End date

2028-03-01

Registry ID

NCT07444788

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.